RaQualia Pharma and Veritas In Silico announce that both companies have achieved the milestone in a joint research collaboration for mRNA-targeted small molecule drug discovery

Cookie Policy

We use cookies to provide you with a better browsing experience.
Please confirm that you agree to our use of cookies by clicking Yes.
If you continue to browse this website even without agreeing to our use of cookies,
we consider that you have consented to our use of cookies.

Privacy Policy